Dd. Branisteanu et al., PARTIAL PREVENTION OF ACTIVE HEYMANN NEPHRITIS BY 1-ALPHA,25 DIHYDROXYVITAMIN D-3, Clinical and experimental immunology, 94(3), 1993, pp. 412-417
The hormone 1 alpha, 25 dihydroxyvitamin D-3 (1,25(OH)(2)D-3) has pote
nt immunosuppressive effects in vitro. Recent publications also descri
bed a protective effect of the hormone in various animal models of imm
une-mediated diseases. To test its in vivo activity we induced active
Heymann nephritis in Lewis rats that were either untreated or treated
with 1,25(OH)(2)D-3 or its synthetic 20-epi analogue, KH1060. Treatmen
t with cyclosporine A (CsA) was used as an immunosuppressive control.
In this nephrotic model the administration of 1,25(OH)(2)D-3 (0.5 mu g
/kg body weight) given on alternate days during the first 13 days afte
r active immunization significantly reduced the proteinuria as measure
d by weeks 7-9. This reduction was comparable to the reduction observe
d in rats treated with CsA (20 mg/kg) on alternate days. A second seri
es of experiments with 1,25(OH)(2)D-3 confirmed these findings. The le
vel of autoantibodies was found to be significantly suppressed during
the treatment time in the CsA (20 mg/kg) group, whereas the limit of s
ignificance (P=0.06) was reached in the 1,25(OH)(2)D-3 (0.5 mu g/kg) g
roup. The size of the immune deposits also was found to be substantial
ly smaller in the groups that developed less proteinuria. The administ
ration of 1,25(OH)(2)D-3 transiently increased the mean serum calcium
concentration with 2.5 mg/dl above the pretreatment values, and the ur
inary calcium excretion by a factor of 3-5 during the short treatment
time. Treatment with the analogue KH1060 did not reduce the proteinuri
a significantly. Our experiments add evidence to the hypothesis that 1
,25(OH)(2)D-3 in pharmacological doses has immunosuppressive potency.